SCD — Zentiva SA Income Statement
0.000.00%
HealthcareBalancedMicro Cap
Annual income statement for Zentiva SA, fiscal year end - December 31st, RON millions except per share, conversion factor applied.
2020 December 31st | C2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | PRESS |
Standards: | IFRS | IFRS | IFRS | IFRS | — |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 558 | 711 | 760 | 954 | 1,114 |
Cost of Revenue | |||||
Gross Profit | 276 | 393 | 404 | 494 | 664 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 485 | 595 | 673 | 769 | 865 |
Operating Profit | 73.3 | 116 | 86.3 | 185 | 249 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 80.5 | 119 | 115 | 222 | 287 |
Provision for Income Taxes | |||||
Net Income After Taxes | 65.6 | 106 | 99.5 | 193 | 259 |
Net Income Before Extraordinary Items | |||||
Net Income | 65.6 | 106 | 99.5 | 193 | 259 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 65.6 | 106 | 99.5 | 193 | 259 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.098 | 0.156 | 0.147 | 0.277 | 0.37 |
Dividends per Share |